NCT05457699View on ClinicalTrials.gov

Ablative Radiotherapy to Consolidate Maximal Systemic Response in Metastatic Prostate Cancer (ANCHOR-Prostate)

PHASE2RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

December 30, 2022

Primary Completion Date

July 30, 2025

Study Completion Date

July 30, 2030

Conditions
Prostate Cancer Metastatic
Interventions
RADIATION

SABR

SBAR to PSMA-PET visible disease at maximal systemic therapy response.

OTHER

no RT

no SABR, continued systemic therapy per SOC

Trial Locations (1)

H2X 0A9

RECRUITING

CRCHUM, Montreal

All Listed Sponsors
lead

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER